Hospitalist Demand: Growing Expertise, Increasing Expectations | Medscape
The landscape of hospital medicine is shifting, and with it, the demands placed on hospitalists – physicians who specialize in the care of hospitalized patients – are set to increase. While the core function remains constant, the evolving needs of healthcare systems and a deeper understanding of complex conditions are poised to reshape the role in the coming year. This isn’t about fundamentally altering what hospitalists do, but rather recognizing that their expertise will be increasingly sought after as healthcare becomes more nuanced.
Finerenone and Heart Failure Management: A New Consideration
Recent research is prompting a closer look at treatment options for heart failure, particularly in patients with mildly reduced or preserved ejection fraction (HFmrEF and HFpEF). The FINEARTS trial, presented at SHM Converge 2025, investigated the apply of finerenone, a non-steroidal mineralocorticoid receptor antagonist, in these patient populations. Traditionally, steroidal mineralocorticoid receptor antagonists have been recommended for heart failure with reduced ejection fraction (HFrEF) and considered for HFmrEF and HFpEF, but the FINEARTS trial suggests finerenone may offer a statistically significant reduction in heart failure events and cardiovascular death.
The study, involving over 6,000 participants with a mean age of 72 and a mean ejection fraction of 64%, demonstrated a number needed to treat of 30 to see a benefit. In other words that for every 30 patients treated with finerenone, one fewer experienced a worsening heart failure event or death. While promising, it’s important to understand that this is a statistical measure and doesn’t guarantee a specific outcome for any individual patient. The trial also included patients already using sodium glucose co-transporter 2 inhibitors (SGLT2i), a relatively small percentage (13%), which could influence the broader applicability of the findings.
Mineralocorticoid receptor antagonists work by blocking the effects of aldosterone, a hormone that can contribute to fluid retention and inflammation in the heart. The difference between steroidal and non-steroidal versions lies in their chemical structure and potential side effects. Finerenone’s non-steroidal nature may offer a different side effect profile, but further research is needed to fully understand these differences.
The Evolving Financial Landscape for Hospitalists
Alongside clinical advancements, the economic realities of hospital medicine are also in flux. According to Medscape’s 2024 Hospitalist Compensation Report, the average hospitalist earned $321,000 in 2023, a modest increase of $5,000 from the previous year. This relatively sluggish growth in compensation comes as hospitalists continue to manage a high patient load – averaging 71 patients per week – and navigate increasing administrative burdens.
The report also reveals a complex picture of job satisfaction. While a majority (73%) of hospitalists would choose a medical career again, just over half (51%) feel fairly compensated for their work demands. A significant portion (58%) believe that most U.S. Physicians are underpaid. Many hospitalists (50%) are taking on extra work to supplement their income, and they work, on average, four more hours per week than their non-hospitalist counterparts. The two most frequently cited frustrations with the job are dealing with difficult patients (22%) and navigating the sheer volume of rules and regulations (22%).
Interestingly, compensation wasn’t a primary motivator for entering the field for most hospitalists. For 41% it wasn’t a factor at all, and for another 39% it was only a minor consideration. This suggests that a strong sense of purpose and dedication to patient care remain central to the profession.
What This Means for Patient Care
The convergence of these trends – increasing clinical complexity and a potentially strained financial environment – has implications for patient care. As hospitalists are asked to incorporate new evidence, like the findings from the FINEARTS trial, into their practice, they will need access to ongoing education and resources. The demand for specialized knowledge in areas like heart failure management will likely grow, requiring hospitalists to stay abreast of the latest research and guidelines.
The financial pressures could also impact the ability to attract and retain qualified hospitalists, potentially leading to staffing shortages in some areas. This, in turn, could increase workloads and potentially compromise the quality of care. It’s crucial for healthcare systems to address these financial concerns to ensure that hospitalists are adequately supported and able to provide the best possible care to their patients.
The Role of Hospitalists: Beyond Clinical Expertise
The core message remains consistent: hospitalists are becoming increasingly vital as healthcare evolves. Their expertise isn’t just about managing acute illnesses; it’s about coordinating care, navigating complex medical histories, and ensuring a smooth transition for patients as they move between different healthcare settings. This requires strong communication skills, a collaborative approach, and a commitment to lifelong learning.
As Medscape Medical News highlights, hospitalists will be asked for more as their expertise grows. This isn’t necessarily a burden, but rather a recognition of their value and a call to continue refining their skills and knowledge.
Looking Ahead: Ongoing Research and Guidance Updates
The implications of the FINEARTS trial are still being evaluated by leading cardiology organizations. Expect to see further discussion and potential updates to clinical guidelines as more data become available. Ongoing research will also be crucial to determine the long-term effects of finerenone and to identify which patients are most likely to benefit from this treatment. Similarly, continued monitoring of hospitalist compensation and workload will be essential to address the financial and professional challenges facing this critical workforce. Healthcare systems will need to proactively address these issues to ensure the sustainability of high-quality hospital medicine.